Early research (Phase 1)Looking for participantsNCT06363006
What this trial is testing
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 40